Adjuvant therapy in the treatment of non-small-cell lung cancer

Anne M. Traynor, Joan H. Schiller

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.

Original languageEnglish (US)
Pages (from-to)161-167
Number of pages7
JournalClinical Lung Cancer
Volume4
Issue number3
StatePublished - Nov 2002

Fingerprint

Adjuvant Radiotherapy
Non-Small Cell Lung Carcinoma
Adjuvant Chemotherapy
Patient Selection
Recurrence
Survival
Therapeutics

Keywords

  • Chemotherapy
  • Postoperative period
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Pulmonary and Respiratory Medicine

Cite this

Traynor, A. M., & Schiller, J. H. (2002). Adjuvant therapy in the treatment of non-small-cell lung cancer. Clinical Lung Cancer, 4(3), 161-167.

Adjuvant therapy in the treatment of non-small-cell lung cancer. / Traynor, Anne M.; Schiller, Joan H.

In: Clinical Lung Cancer, Vol. 4, No. 3, 11.2002, p. 161-167.

Research output: Contribution to journalArticle

Traynor, AM & Schiller, JH 2002, 'Adjuvant therapy in the treatment of non-small-cell lung cancer', Clinical Lung Cancer, vol. 4, no. 3, pp. 161-167.
Traynor, Anne M. ; Schiller, Joan H. / Adjuvant therapy in the treatment of non-small-cell lung cancer. In: Clinical Lung Cancer. 2002 ; Vol. 4, No. 3. pp. 161-167.
@article{4d7f2f65d83449a3a4aeabd907462c54,
title = "Adjuvant therapy in the treatment of non-small-cell lung cancer",
abstract = "Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.",
keywords = "Chemotherapy, Postoperative period, Radiotherapy, Surgery",
author = "Traynor, {Anne M.} and Schiller, {Joan H.}",
year = "2002",
month = "11",
language = "English (US)",
volume = "4",
pages = "161--167",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Adjuvant therapy in the treatment of non-small-cell lung cancer

AU - Traynor, Anne M.

AU - Schiller, Joan H.

PY - 2002/11

Y1 - 2002/11

N2 - Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.

AB - Randomized trials to date have not consistently demonstrated a benefit in overall survival with the use of adjuvant chemotherapy, radiotherapy, or combined modality chemoradiation in patients with resected non-small-cell lung cancer. Subset analyses suggest a reduction in local relapse with adjuvant radiotherapy for patients with completely resected N2 disease. Improvements in patient selection and treatment plans are urgently needed.

KW - Chemotherapy

KW - Postoperative period

KW - Radiotherapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0036868673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036868673&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 161

EP - 167

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 3

ER -